Condition
    Effectiveness 2/5

    Omega-3 Fatty Acids for Tourette Syndrome

    Omega-3s are occasionally studied in tic disorders because of their role in brain development and inflammation, but trials in Tourette syndrome are small and inconsistent. Behavioral therapy (CBIT) remains the best-supported treatment.

    Overview

    Omega-3s are occasionally studied in tic disorders because of their role in brain development and inflammation, but trials in Tourette syndrome are small and inconsistent. Behavioral therapy (CBIT) remains the best-supported treatment.

    Verdict

    Insufficient evidence

    How It Works

    DHA is a structural component of neuronal membranes and dopamine signaling — pathways implicated in tics — providing a theoretical rationale, though the link to tic severity is speculative.

    Dosing & Protocol

    Typical dose

    Recommended dose
    No dose is established for Tourette syndrome
    Expected timeframe
    Not established

    Protocol

    form
    Not applicable
    duration
    Not applicable
    co factor
    Evidence is insufficient and close to negative: a randomised controlled trial of omega-3 in children with Tourette syndrome found no reduction in tic severity, though it reported some improvement in tic-related impairment. Comprehensive behavioural intervention for tics (CBIT) is the first-line treatment, with alpha-2 agonists or antipsychotics where tics are disabling.
    titration
    Not applicable
    starting dose
    Not applicable as a treatment

    Evidence

    What the studies say

    One small pilot trial of omega-3 in Tourette's showed trends toward tic reduction without statistical significance. Evidence is far too weak to recommend omega-3 as a tic treatment; it remains a reasonable general-health supplement, not a therapy.

    A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder

    Score: 7/10
    2012
    rct

    Omega-3 fatty acids did not reduce total tic scores versus placebo in children with Tourette's disorder, though tic-related impairment improved.

    View source

    Safety

    Caveats

    Tics wax and wane naturally, so apparent responses to any supplement are usually coincidence. Do not delay CBIT, which has the strongest evidence. Safety ceiling: keep below 3 g/day EPA+DHA in adults and proportionately less in children; higher raises bleeding risk. Use products third-party tested for mercury and PCBs in children, and avoid cod liver oil because of vitamin A load. Co-occurring OCD and ADHD often cause more impairment than the tics and should be assessed.

    Less likely to help if

    Everyone for tic severity - the controlled trial was negative on that outcome.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.